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Abstract
Targeted interventions to slow or postpone ageing and to favour an active life expectancy represent the new 
perspectives in ageing investigation. Some mechanisms that delay or prevent the onset of ageing disabilities and 
pathologies have been identified. In general, maintaining a healthy lifestyle seems to reduce many risk factors. In 
particular, eating habits represent the most concrete and low-cost method to address ageing. Of all dietary habits 
analysed, the Mediterranean diet has received much attention since it has consistently proven its beneficial influence 
on health and longevity. The Mediterranean diet is characterized by low glycaemic index and low animal protein 
intake, it is rich in nutraceuticals and functional foods thus reducing molecular pathways signalling, as nutrient 
sensitive pathways which affect the ageing process and lead to unhealthy ageing. This dietary model can be promoted 
as an “anti-ageing therapy” and can contribute to good health status and therefore to a better quality of life.
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Introduction: healthy foods for healthy ageing
Healthy ageing as well as the occurrence of age-
related disabilities and diseases result from several 
degrees of interaction between genetic, epigenetic 
and environmental factors1. To reach an active and 
independent end of life and to achieve a healthy life-
span, the so called health-span, an integrative approach 
is needed2. With the aim of developing preventive and 
therapeutic measures, it is important to start managing 
daily habits. Nutrition is probably the most important 
one3,4.  Our life, in different ways, turns around food. 
It can be a positive or negative relationship. It can be 
a reason for travelling or for working but no one can 
live without it.
Since ageing is an ineluctable process, the goal is to 
live longer but in good health rather than just delaying 
the end of life.
The Mediterranean Diet (MedDiet) is a cultural tradition 
that contributes to better health and quality of life 
in Mediterranean countries, where many longevous 
people exist. In fact, the Elderly Prospective Cohort 
Study identified a reduced overall mortality among old 
people who live in the Mediterranean way5,6.
For many years, interventions to slow the rate of 
ageing and increase life-span have been tested by 
many scientists. They have tried and succeeded in 
modulating the nutrient-sensing pathways (NSPs) and 
in revealing new and interesting research suggestions 
in the field of anti-ageing medicine2. In both animal 
models and humans dietary intervention can decrease 
the chronic, generalized pro-inflammatory status, 
the inflammageing, positively modulating the 
ageing process7-9. The complex relationship between 
nutrition, the ageing process and healthy ageing is 
not completely understood.  Specific dietary changes 
however, as recommended by NU-AGE project, such 
as the reduction or elimination of trans and saturated 
fats and an increased intake of omega-3 fatty acids, 
vitamins, minerals and antioxidants can help to 
minimize inflammation10.
Similarly, appropriate intake of functional foods may 
confer health benefits, influencing the maintenance of 
immune homeostasis and contributing, directly, to the 
reduction of inflammation and metabolic disorders 
related to an inadequate diet11,12.
In this review we evaluate the relationship between 
adherence to the MedDiet, rich in bioactive compounds, 
and healthy ageing, underlying its activating or 
inhibitory role in cellular pathways and the anti-ageing 
effects of its functional foods.
Ageing and longevity
Ageing is a complex, unavoidable phenomenon or trait 
than cannot be exhaustively defined. 
In May 2012, a group of scientists and clinicians met 
in Athens to consider the relevance of ageing and 
longevity. The workshop led to the creation of a statement 
to highlight the importance of a common view related 
to these processes, since they represent phenotypes that 
are rapidly spreading worldwide.
The panel defined ageing as a process which makes 
people more vulnerable, leading to death but in a distinct 
moment of the chronological age (CA) as compared to 
the biological age (BA)13.
The United Nations define “elderly” all individuals from 
the age of 60 years old14. Of course it can be considered 
only a necessary threshold in order to classify the 
population.
We are however interested in how long people live and 
remain engaged and physically active so the simplistic 
classification, based on the CA, is only theoretical and 
not very useful. CA refers to the date of birth, while BA 
is a personal feature that depends on how old a person 
appears to be. These two parameters often do not match. 
The BA is a dynamic concept, based on the biological 
health status of tissues, organs and systems15.
By definition there are two ways to become old, i.e. 
with success (successful ageing) and without success 
(unsuccessful or pathological ageing). The ratio between 
CA and BA is greater than or equal to 1 in successful 
ageing and less than 1 in unsuccessful ageing.
Unsuccessfull ageing is manifested by people who develop 
one or more age-related diseases, such as neurodegenerative 
(Alzheimer’s or Parkinson’s) diseases, metabolic (metabolic 
syndrome and type 2 diabetes mellitus) and cardiovascular 
diseases (myocardial infarction and atherosclerosis) and 
cancer13,16. In fact, ageing is due to the loss of molecular 
fidelity that varies among different subjects, leading to 
both dangerous and non-dangerous features that can 
reduce the adaptation to the environment, involving 
DNA, cells, tissues and the whole system17. It results 
in compromised stress response, greater homeostatic 
imbalance, elevated risk of disease and, consequently, 
death15,17.
Instead, successful ageing implies the avoidance (or the 
late onset) of diseases and disabilities with a preservation 
of cognitive and physical functions13.
Centenarians represent the best model of successful ageing.
They live longer than the rest of the population and without 
any relevant disease, thanks to a favourable genetic 
background and to a good response to adverse environmental 
conditions13. In 2012, Caruso et al. conducted a study in 
a small area of Sicily, the Sicani Mountains, where the 
number of centenarians is high.
These areas showed low mortality rate for cancer and 
cardiovascular disease. The centenarians recruited 
tended to be physically active and to have a healthy diet, 
contributing to inflammation reduction18,19.
On the other hand, physical inactivity and hypercaloric 
diet lead to an accumulation of visceral fat and 
infiltration of pro-inflammatory macrophages and 
T-cells in adipose tissue.
Moreover, adipose tissue releases adipokines and other 
pro-inflammatory cytokines, causing inflammation20.
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The centenarians’ ability to reach the age of 100 in the 
Westernized countries and the reduction in overall 
mortality reflect the improvement of hygienic condition, 
the reduced exposure to infection and inflammation, 
the overall improvement of the quality of life, the 
attention to the diet and the advent of therapeutic and 
preventive medicine15,21.
Mediterranean Diet
MedDiet is one of the most studied healthy dietary 
patterns. It represents more than an alimentary regimen. 
It can be considered a life-style that characterizes 
people, groups, regions and countries with similar 
but, at the same time, different ways to eat. As many 
studies demonstrated, MedDiet can positively influence 
several parameters, such as abdominal obesity, 
dyslipidaemia, elevated blood pressure and impaired 
glucose tolerance all being factors that predispose 
to onset of age-related diseases. Large intervention 
trials showed that MedDiet could prevent or delay age-
related diseases with a great implication for health 
and social system22-26. Since 1995, this dietary pattern 
is represented by a pyramid updated over the years. 
The current one suggests a daily consumption of plant 
foods (fruit, vegetables, nuts, seeds, olives, herbs and 
spices), whole cereals, extra virgin olive oil (EVOO) as 
main source of fat, dairy products (principally cheese 
and yogurt, preferably low fat) and weekly consumption 
of poultry, fish, eggs (two to four) and legumes. Red and 
cured meats and sweets can be consumed in very low 
amount and red wine can be consumed responsibly 
during meals27.  So, this diet consists with a low animal 
protein intake. It is hypocaloric, characterized by a low 
amount of saturated fats, cholesterol and sugars, and a 
high content of fibres25.  Its beneficial effects could also 
be attributable to the presence of nutraceuticals and 
functional foods, other than only to the low glycaemic 
index (GI) and to the low animal protein and caloric 
intake25.  Nutraceuticals are Naturally derived bioactive 
compounds that are found in foods, dietary supplements 
and herbal products; they have health-promoting, 
disease-preventing or medicinal properties28,29. They 
have antioxidant and anti-inflammatory effects that 
confer to MedDiet anti-ageing properties. In particular, 
fruit and vegetables are important sources of 
nutraceuticals such as polyphenols, as well as fish and 
red wine, rich in omega-3 fatty acids and resveratrol, 
respectively9,30. All of these belong to the big family of 
functional foods. Although a universal definition for 
them does not exist, the Functional Food Center defined 
them as Natural or processed foods that contain known 
or unknown biologically-active compounds which, in 
defined, effective non-toxic amounts provide a clinically 
proven and documented health benefit for the prevention, 
management or treatment of chronic disease31.
Mediterranean diet as a strategy to modulate ageing
As previously stated, Mediterranean functional foods 
contain bioactive compounds with anti-inflammatory 
and anti-oxidant effects that can confer health benefits, 
contributing directly to the reduction of the inflammatory 
status and of metabolic disorders related to an unhealthy 
diet9,25,29.
Thanks to the studies on the positive contribution of 
MedDiet to the extension of life-span in healthy condition, 
it can be considered a strategy to delay ageing. In fact, 
it is characterized by low GI and low animal protein 
intake and it is able to act directly on specific metabolic 
pathways, called NSPs9,25. 
The NSPs are signalling cascades activated by the 
level of nutrients, such as carbohydrates or protein (or 
aminoacids). The most representative are the insulin/
insulin-like growth factor-1 (IGF-1) and the target of 
rapamicin (TOR) pathways. From yeast to human, they 
are genetically conserved although, of course, the 
molecular complexity varies among them8,32. 
Insulin and IGF-1 levels are, respectively, influenced by 
glucose and growth hormone (GH). During fasting, both 
GH and insulin decrease with a consequent reduction 
of IGF-1 circulating levels and a delay in the ageing 
process, as presented by several model organisms33. 
The insulin/IGF-1 signalling cascade starts from the 
binding of insulin or IGF-1 to the insulin or IGF-1 receptor 
(IGF-1R) that triggers, inside the cell, many molecular 
events, such as the activation of the phosphoinositide 
second messenger.
It leads to the activation of AKT that can stimulate the 
nuclear factor kappa-light-chain-enhancer of activated B 
cells (NF-κB) signalling, involved in immune inflammatory 
mechanisms34,35. The translocation of NF-κB to the nucleus 
and its binding to the DNA triggers the transcription of a 
number of genes, including pro-inflammatory cytokines, 
chemokines, adhesion molecules, eicosanoids, growth 
factors, metallo-proteinases, nitric oxide, etc34.
The modulation of this pathway, possibly due to low 
glycaemic and protein intake and, maybe, to some 
antioxidant and anti-inflammatory molecules, may 
lower insulin/IGF-1 signal and stimulate the action of 
different transcription factors (TFs)36. 
Forkhead box O 3A (FOXO3A), extensively studied for 
its role in longevity, is one of these TFs, involved in the 
transcription activation of molecules that take part in 
cellular homeostasis. The gene encoding for this protein 
belongs to the FOXO family which has a typical DNA-
binding forkhead box domain. It is one of the orthologue 
of DAF-16 in Caenorhabditis elegans (C. elegans), a TF 
involved in stress resistance and longevity37,38. In 
addition, FOXO3A interacts with sirtuins (SIRTs), a 
family of histone deacetylase enzymes, identified as 
anti-ageing molecules in model organisms. SIRT1, one 
of the seven human sirtuin isoforms, SIRT1-SIRT7, 
deacetylates FOXO3A modulating its response to 
oxidative stress39. In mammals, downstream of IGF-
1R, there is the mammalian TOR (mTOR) composed by 
mTOR complex 1 (mTORC1) and the mTOR complex 2. 
mTORC1 is activated by insulin and IGF-1, modulating 
growth, metabolism, and stress response through 
regulation of transcription, translation and autophagy, 
a cytoprotective process. Its inhibition by the protein 
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kinase AMP, a key sensor of the cellular energy state, 
activated by low levels of ATP, causes stress resistance 
and reduced age-related inflammatory status by the NF-
κB pathway40. 
Decreased TOR activity extends longevity also in C. 
elegans41,42 and Drosophila melanogaster43. In addition, its 
reduction in a mouse genetic model reduces the incidence 
of some age-related diseases, including cancer44. 
So, in humans, MedDiet, with its low intake of amino 
acids and low GI, might directly modulate the insulin/
IGF-1 and the TOR pathways trough a down-regulation 
of the signals that lead to the activation of FOXO and, 
consequently, to the transcription of homeostatic genes 
that favour longevity thus decreasing inflammatory 
status and oxidative stress25,45,46.
The Mediterranean hormetic effect 
Many components of the MedDiet are known to have 
healthy properties. The abundance in mono and 
polyunsaturated fatty acids (MUFAs and PUFAs), fibres, 
vitamins, minerals and, more generally, nutraceuticals 
plays a key role in inflammation reduction and oxidative 
stress response, acting on important risk factors for 
age-related diseases25,47,48.
Moreover, nutraceuticals stimulate a hormetic response49,50.
In 1943, Chester Southam and John Ehrlich described51, 
for the first time, the phenomenon of hormesis. The 
term comes from the Greek word ὅρμησις that means 
rapid motion. As it was then defined in 2002, it is a 
biphasic dose response phenomenon, characterized by a 
low dose stimulation and a high dose inhibition52. 
In biology and medicine, hormetic effect is an adaptive 
response of cells and organisms to moderate (usually 
intermittent in terms of intensity) stress, such as a low 
dose of chemical agent or environmental factor that 
induces an adaptive beneficial effect. On the contrary, 
the same stimulus is detrimental at higher doses53. 
In nutrition, hormetins are molecules that can activate 
the hormetic process; they are produced by plants as a 
protection against microorganisms, insects and other 
environmental agents54. Some examples of nutritional 
hormetins are phenolic acids, polyphenols, flavonoids, 
ferulic acid geranylgeranyl, rosmarinic acid, kinetin, 
zinc and the extracts of tea, dark chocolate, etc55.  
In human beings, as a reaction to damage, they likely 
activate stress response pathways, such as the NSPs, in 
cells as for example after exposure to mild heat stress56. 
The activation of NSPs results in increased production 
of homeostatic genes and therefore proteins such as 
heat-shock and others involved in the regulation of 
cellular energy metabolism or antioxidant enzymes57. 
For example, the isothiocyanates are active compounds 
obtained from the conversion of glucosinolates by 
myrosinase, a glucosidase possibly present in human 
microbiota contained in cruciferous vegetables (cauliflower, 
broccoli sprouts, cabbage, broccoli and similar green leafy 
vegetables) typical of the MedDiet. Inside the cell, they 
stimulate the activation of the nuclear factor erythroid 
2-related factor 2 that, consequently, translocates to 
the nucleus, binding the antioxidant response element, 
encoding antioxidant enzymes58.
Polyphenols, classified as phenolic acids, flavonoids, 
stilbenes and lignans, phytochemicals widely present 
in fruits and vegetables, including the Mediterranean 
ones, can regulate the TF NF-κB by reducing the 
expression of inflammatory cytokines and can activate 
SIRT1 that may also inhibit NF-κB, reducing the cellular 
stress response59-61. On the other hand, SIRT1 acts on 
FOXO3A which, as previously stated, modulates genes 
that encode antioxidant enzymes and other stress-
response proteins25,62. 
MedDiet effects on gene expression therefore cause a 
successful response to environmental changes, allowing 
better use of nutritional resources and determining 
epigenetic modifications25,63.
Phytochemicals, as well as other nutrients, can also 
influence miRNA expression, a class of small non-coding 
RNA (19-24 nucleotides) evolutionary conserved that, 
in turn, regulate post-translational gene expression, 
suppressing the translation or reducing the mRNA target 
stability64. Moreover, it has been demonstrated that 
polyphenols can modulate miRNA action on metabolic 
homeostasis and on chronic diseases but further studies 
are necessary to identify their targets64-66.
Mediterranean functional food: the example of EVOO 
and table green olives
As previously stated, typical Mediterranean foods contain 
phytochemicals, defined as chemical compounds produced 
by plants. They are often characterized by phenolic 
groups, good source of natural antioxidants that may 
affect health with their anti-inflammatories and anti-
cancer properties25.
EVOO, the main and common food in the Mediterranean 
basin, is the principal source of fats in the MedDiet 
regimen. It has many nutraceutical properties thanks to 
the complex mixture of bioactive compounds67.
Several studies have shown that it decreases pro-
inflammatory environment induced by oxidized low-
density lipoproteins (LDLs) both in experimental models 
and in humans, reducing the levels of C reactive protein, 
a powerful marker of inflammation, and the levels of 
pro-inflammatory cytokine interleukin-6 (IL-6)68-70. 
With its high content in MUFAs and polyphenols, EVOO 
might exert beneficial effects on the development and 
progression of age-related diseases. In fact, its non-
saponifiable portion (1-2%) contains about 230 bioactive 
molecules, such as carotenoids, mainly lycopene, sterols, 
and the phenolic compounds oleoeuropein, oleocanthal, 
hydroxytyrosol and tyrosol, with antioxidant and anti-
inflammatory properties67,70. Oleic acid is the main 
MUFA and is claimed to increase the resistance of LDL 
to oxidation. It has also been suggested that MUFAs can 
decrease all-cause (11%) and cardiovascular mortality 
(12%), cardiovascular events (9%) as well as stroke (17%)68. 
Moreover, in models, oleic acid suppresses cytotoxic 
function of natural killer cells with a consequent anti-
inflammatory effect, although it is simply a possible 
lower response to microorganism infection71.
In general, unsaturated fatty acids improve endothelial 
function, decreasing intercellular adhesion molecule-1 
production by endothelial cells and reducing leukocyte 
adhesion72. In fact both in vitro and in vivo studies 
demonstrated the endothelium-protective properties of 
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these molecules68,70,73-76.
Some trials showed that polyphenols intake has been 
associated with low mortality rates caused by coronary 
heart disease77,78.
These compounds are able to bind LDLs, increasing 
resistance to oxidation and acting as radical scavengers79. 
Moreover, it was observed that the consumption of 
polyphenol-rich olive oil could decrease blood pressure 
(BP) and improve endothelial function in young women 
with high-normal BP75.
Generally, polyphenols inhibit NF-κB pathway that 
leads to the expression of pro-inflammatory genes80-82. 
In particular hydroxytyrosol and oleocanthal have 
ibuprofen-like activity, inhibiting the cyclooxygenases 
1 and 2, responsible for prostaglandin production70,80. 
As reported in a recent review, also green table olives 
are an extremely rich source of polyphenols, especially 
oleuropein and hydroxytyrosol, comprising 1-3 % of 
fresh pulp weight. 
Despite the high levels of hydroxytyrosol in both table 
olives and EVOO, in humans its bioavailability was 
proven only in oil83. The amount of polyphenols in 
olives, as well as in oil, is strongly influenced by the 
variety and the geographical origin. Greek Koroneiki 
have a very high content, while polyphenol content of the 
Spanish Arbequina is low and that of Sicilian Nocellara 
is medium-high67, with a conceivable anti-inflammatory 
and anti-oxidant effect.
In 2013, a new compound was extracted from the 
wastewaters obtained during olive oil production from 
Nocellara del Belice olives. This compound, known as 
nocellaralactone, is also present in the leaves and appears 
to be structurally similar to monoterpenoids, secondary 
metabolites found in higher plants, with a significant 
in vitro anti-inflammatory activity84. Moreover, a pilot 
study demonstrated that daily consumption of table 
green olives Nocellara del Belice is likely linked to a 
decrease in IL-6 and malondialdehyde (MDA) levels85.
MDA is the main product of PUFAs peroxidation and is 
an important index of oxidative stress86.  Noteworthy, 
this study highlighted a reduction of fat mass with 
an increase of muscle mass in subjects recruited for 
nutritional intervention. The possible explanation could 
be linked to the capacity of conjugated linoleic acid (CLA) 
to reduce body fat levels, strictly linked to production of 
adipokines (pro-inflammatory cytokines)87.
CLA is present both in EVOO and table olives and can 
also be produced during their digestion.
In experimental models, acting as signalling mediator, 
CLA inhibits lipogenesis, increases fat oxidation and 
reduces adipocytes size88,89.
In fact, such levels significantly decreased at the end of 
the dietary intervention. 
Conclusion
The extraordinary increase of elderly population in 
developed countries underscores the importance of 
studies on ageing and longevity and the need for a 
prompt spread of knowledge about these topics, in 
order to satisfactorily decrease medical, economic and 
social problems associated with old age.
In fact, European public health policy focuses its 
attention on the achievement of a healthy lifespan 
which represents an important challenge16,90. 
According to positive biology, an effective approach is 
needed to understand the causes of positive phenotypes 
to try and explain the biological mechanisms of healthy 
ageing, rather than making age-related diseases the 
central focus of research91.  Much evidence shows that 
dietary restriction2,8 as well as allelic variations in gene 
encoding proteins that take part in NSPs can increase 
lifespan62,92-99. This phenomenon is evolutionary 
conserved but the achievement of dietary restriction 
is not easy in human beings because it implies a 
considerable caloric restriction. A close daily adherence 
to MedDiet, including a healthy lifestyle, seems to be one 
of the more realistic ways to apply dietary restriction. 
Moreover, the possibility of managing this pattern, 
based on the combined use of functional foods, should 
permit to create a new therapeutic strategy. It would 
be based not only on a specific bioactive molecule or 
on a specific food but also on an integrated approach. 
Starting from local dietary habits, it can be extended to 
a nutra-functional diet applicable worldwide. 
Oxidative stress and low grade inflammation play a 
part in the pathogenesis of age-related diseases and 
consequently in the ageing process. Thus, it is very 
relevant to study in greater depth the mechanism of 
action of nutraceuticals contained in functional foods 
that may constitute a natural remedy with health 
benefits through the reduction of cellular and tissue 
damage with the final aim to prevent or fight age-
related diseases100. 
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